165 related articles for article (PubMed ID: 8888720)
1. Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer.
Brummer RJ; Stockbrügger RW
Dig Dis Sci; 1996 Oct; 41(10):2048-54. PubMed ID: 8888720
[TBL] [Abstract][Full Text] [Related]
2. Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial.
Lin HJ; Lo WC; Cheng YC; Perng CL
Clin Ther; 2006 Sep; 28(9):1303-7. PubMed ID: 17062303
[TBL] [Abstract][Full Text] [Related]
3. Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease.
Thomson AB; Mahachai V; Bailey RJ; Kirdeikis P; Zuk L; Marriage B; Simpson I; Jamali F
J Gastroenterol Hepatol; 1996 Dec; 11(12):1171-6. PubMed ID: 9034938
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.
Thomson AB; Keelan M; Lastiwka R; Appelman-Eszczuk S; Zuk L; Drozdowski L; Prentice A; Sinclair P
Dig Dis Sci; 2003 Oct; 48(10):2045-56. PubMed ID: 14627354
[TBL] [Abstract][Full Text] [Related]
5. Intravenous omeprazole rapidly raises intragastric pH.
Walt RP; Reynolds JR; Langman MJ; Smart HL; Kitchingman G; Somerville KW; Hawkey CJ
Gut; 1985 Sep; 26(9):902-6. PubMed ID: 4029717
[TBL] [Abstract][Full Text] [Related]
6. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.
Xue S; Katz PO; Banerjee P; Tutuian R; Castell DO
Aliment Pharmacol Ther; 2001 Sep; 15(9):1351-6. PubMed ID: 11552905
[TBL] [Abstract][Full Text] [Related]
7. A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer.
Sheu BS; Chi CH; Yang HB; Jen CM; Lin XZ
Hepatogastroenterology; 1999; 46(28):2363-71. PubMed ID: 10521999
[TBL] [Abstract][Full Text] [Related]
8. Lack of gastric acid rebound after stopping a successful short-term course of nizatidine in duodenal ulcer patients.
Savarino V; Mela GS; Zentilin P; Sumberaz A; Bonifacino G; Celle G
Am J Gastroenterol; 1991 Mar; 86(3):281-4. PubMed ID: 1671805
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer.
Labenz J; Tillenburg B; Peitz U; Idström JP; Verdú EF; Stolte M; Börsch G; Blum AL
Gastroenterology; 1996 Mar; 110(3):725-32. PubMed ID: 8608881
[TBL] [Abstract][Full Text] [Related]
10. Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele MR; Perilli D; Vassallo A; Zambotti A; Mansi C; Celle G
Dig Dis Sci; 1994 Jul; 39(7):1473-82. PubMed ID: 8026259
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients.
Cederberg C; Thomson AB; Mahachai V; Westin JA; Kirdeikis P; Fisher D; Zuk L; Marriage B
Gastroenterology; 1992 Sep; 103(3):913-8. PubMed ID: 1499942
[TBL] [Abstract][Full Text] [Related]
12. Effect of daily oral omeprazole on 24 hour intragastric acidity.
Walt RP; Gomes MD; Wood EC; Logan LH; Pounder RE
Br Med J (Clin Res Ed); 1983 Jul; 287(6384):12-4. PubMed ID: 6407676
[TBL] [Abstract][Full Text] [Related]
13. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
[TBL] [Abstract][Full Text] [Related]
14. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group.
Bytzer P; Aalykke C; Rune S; Weywadt L; Gjørup T; Eriksen J; Bonnevie O; Bekker C; Kromann-Andersen H; Kjaergaard J; Rask-Madsen J; Vilien M; Hansen J; Justesen T; Vyberg M; Teglbjaerg PS
Scand J Gastroenterol; 2000 Oct; 35(10):1023-32. PubMed ID: 11099054
[TBL] [Abstract][Full Text] [Related]
15. [Omeprazole in peptic ulceration: acid inhibition and endoscopic healing].
Chen SP; Mai CR; Ke MY
Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):720-1, 767. PubMed ID: 2636088
[TBL] [Abstract][Full Text] [Related]
16. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.
Jones DB; Howden CW; Burget DW; Kerr GD; Hunt RH
Gut; 1987 Sep; 28(9):1120-7. PubMed ID: 2890561
[TBL] [Abstract][Full Text] [Related]
17. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
[TBL] [Abstract][Full Text] [Related]
18. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
19. Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: A randomized prospective study.
Chwiesko A; Charkiewicz R; Niklinski J; Luczaj W; Skrzydlewska E; Milewski R; Baniukiewicz A; Wroblewski E; Rosolowski M; Dabrowski A
J Dig Dis; 2016 Sep; 17(9):588-599. PubMed ID: 27518195
[TBL] [Abstract][Full Text] [Related]
20. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H
J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
